You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: July 16, 2024

HYDROCODONE POLISTIREX AND CHLORPHENIRAMINE POLISTIREX Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Hydrocodone Polistirex And Chlorpheniramine Polistirex, and when can generic versions of Hydrocodone Polistirex And Chlorpheniramine Polistirex launch?

Hydrocodone Polistirex And Chlorpheniramine Polistirex is a drug marketed by Tris Pharma Inc and is included in one NDA.

The generic ingredient in HYDROCODONE POLISTIREX AND CHLORPHENIRAMINE POLISTIREX is chlorpheniramine polistirex; hydrocodone polistirex. There are twenty-nine drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the chlorpheniramine polistirex; hydrocodone polistirex profile page.

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for HYDROCODONE POLISTIREX AND CHLORPHENIRAMINE POLISTIREX?
  • What are the global sales for HYDROCODONE POLISTIREX AND CHLORPHENIRAMINE POLISTIREX?
  • What is Average Wholesale Price for HYDROCODONE POLISTIREX AND CHLORPHENIRAMINE POLISTIREX?
Drug patent expirations by year for HYDROCODONE POLISTIREX AND CHLORPHENIRAMINE POLISTIREX
Recent Clinical Trials for HYDROCODONE POLISTIREX AND CHLORPHENIRAMINE POLISTIREX

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
MallinckrodtPhase 1

See all HYDROCODONE POLISTIREX AND CHLORPHENIRAMINE POLISTIREX clinical trials

Pharmacology for HYDROCODONE POLISTIREX AND CHLORPHENIRAMINE POLISTIREX

US Patents and Regulatory Information for HYDROCODONE POLISTIREX AND CHLORPHENIRAMINE POLISTIREX

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Tris Pharma Inc HYDROCODONE POLISTIREX AND CHLORPHENIRAMINE POLISTIREX chlorpheniramine polistirex; hydrocodone polistirex SUSPENSION, EXTENDED RELEASE;ORAL 091632-001 Oct 1, 2010 RX No Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.